[VIDEO] Voices of Choice - Amir from San Francisco on Being in the iPrEx Open Label PrEP Trial

"It's good, but it's tedious..."

In the video below, Amir from San Francisco discusses his participation in the iPrEx Open Label Study and taking Truvada as a way to prevent HIV infection.

The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.

In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.